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Sequence variations in the Epstein–Barr virus (EBV) latent membrane protein 1 gene have been described in numerous
EBV-associated tumors with some of these variations, most notably a 30-base pair deletion in the cytoplasmic carboxyl-
terminal domain, suggested as associated with an increase in tumorigenicity. In this study, EBV DNA sequence was
determined from 92 tissue specimens or cell lines, including nasopharyngeal carcinoma, oral hairy leukoplakia, post-
transplant lymphoma, post-transplant without pathology, mononucleosis, Burkitt’s lymphoma, parotid tumor, and normal from
distinct geographical regions. The amino- and carboxyl-terminal sequences and, in some cases, the full-length sequences of
latent membrane protein 1 were determined. Characteristic sequence patterns distinguished strains, with the carboxyl-
terminal sequence being the most informative in distinguishing among the strains. Phylogenetic relationships between
strains were determined, as were signature amino acid changes that discriminate between them. A correlation between
strain and disease or strain and geographic location was not detected. The sequence variation and signature sequences
identified at least seven distinct strains, as well as hybrid strains that apparently result from recombination. © 1999 Academic
Press
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LINTRODUCTION
The Epstein–Barr virus (EBV), a ubiquitous human her-
esvirus, is associated with a variety of human neoplas-
ic diseases, some with distinct geographical incidence.
hese neoplastic diseases include Burkitt’s lymphoma
BL) endemic to equatorial Africa; nasopharyngeal carci-
oma (NPC) common to southern China, Mediterranean
frica, and Inuit populations; and post-transplant lym-
homa (PTL) and Hodgkin’s lymphoma (reviewed in
aab-Traub, 1996). EBV is also associated with the non-
eoplastic diseases, infectious mononucleosis (Henle et
l., 1968) and oral hairy leukoplakia (HLP) (Greenspan et
l., 1985).
The EBV-encoded latent membrane protein 1 (LMP1),
onsidered the viral oncoprotein, is expressed in all of
he above pathologies, with the exception of BL. LMP1
an transform rodent fibroblasts (Wang et al., 1985;
aichwal and Sugden, 1988; Moorthy and Thorley-Law-
on, 1993), can induce lymphoma and hyperplasia in
ransgenic mice (Kulwichit et al., 1998), and is essential
or EBV-mediated transformation of B lymphocytes (re-
iewed by Kieff, 1996). Expression of LMP1 leads to
nduction of B cell activation antigens (Wang et al., 1988,
990), the expression of inhibitors of programmed cell
1 To whom reprint requests should be addressed at 309 Lineberger
omprehensive Cancer Center, CB 7295. Fax: (919) 966-3015. E-mail:
rt@med.unc.edu.
79eath, bcl-2 and A20, (Henderson et al., 1991; Laherty et
l., 1992), and the induction of epidermal growth factor
eceptor expression and nuclear factor (NF)-kB activa-
ion through the TRAF signaling pathway (Hammarskjold
nd Simurda, 1992; Miller et al., 1995; Mosialos et al.,
995).
The LMP1 protein has a cytoplasmic amino-terminus,
ix transmembrane domains, and a long cytoplasmic
arboxyl-terminal domain. LMP1 has considerable se-
uence heterogeneity among isolates, and potential
trains have been defined by DNA sequence polymor-
hisms in both the amino- and carboxyl-termini within
his gene (Miller et al., 1994; Sung et al., 1998). These
trains sort independently of the EBV types 1 and 2 that
re distinguished by sequence divergence in the EBV
uclear antigens (EBNAs) (Adldinger et al., 1985; Sample
t al., 1990). Within LMP1, there is an 11-amino-acid
epeat element of varying copy number, which has been
hown to sort independently of the strain (Miller et al.,
994), and a 30-base pair (bp) region that is consistently
eleted in some strains of EBV. It has been suggested
hat some of the sequence variations within LMP1 rep-
esent mutational hotspots and that these changes and
he 30-bp deletion may result in a more aggressive
henotype (Knecht et al., 1993; Kingma et al., 1996). Other
tudies have observed that some variants are geograph-
cally restricted (Chang et al., 1995; Itakura et al., 1996;
eung et al., 1997).The present study was undertaken to identify se-
0042-6822/99 $30.00
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80 EDWARDS, SEILLIER-MOISEIWITSCH, AND RAAB-TRAUBuence patterns in both the amino- and carboxyl-termini
f LMP1, determine signature amino acid changes that
iscriminate between the strains, and determine the re-
atedness between the strains using phylogenetic anal-
sis. Using these discriminating features, the Classifica-
ion and Regression Tree (CART) methodology (Breiman
t al., 1984) was implemented to determine whether
train variation correlated with either disease state or
eographic location.
RESULTS
nalysis of LMP1 amino-terminus and identification of
istinct patterns
DNA sequences from EBV coordinates 169469–169222
rom 77 tissue specimens or cell lines were compared
ith the B95-8 prototype sequence. Definite sequence
atterns were identified, and the samples were grouped
y these sequence patterns (Fig. 1). In keeping with the
revious nomenclature, the strains are named after the
eographic location where they were first isolated, even
hough the strains are not limited to that location. A strain
dentified from NPC specimens and previously desig-
ated, China 1 (Miller et al., 1994; Sung et al., 1998), was
ound in 42 sequence samples, including those from
PCs 2, 3, 5, 10–13, 16, 17, 20–23, 26, 28, 33, 34, 36a, 36b,
7, 38a, 38b, 38c, 39–41, 43, 44, 46–52, 58, 59, 61, 62, 1510,
nd Cao and HLP 2a. In .80% of the isolates, this strain
as bp changes at positions 169425, 169402, 169379,
69361, 169352, 169339, 169286, 169280, 169276, 169274,
69230, 169225, and 169222, with less frequent changes
.54%) at bp 169467, 169437, and 169322 (Fig. 1). These
p changes in the China 1 strain lead to amino acid
hanges at positions 3 H3R (63%), 13 R3P (56%), 17
3L (86%), 25 L3I (91%), 46 D3N (90%), 67 D3H (85%),
2 A3G (82%), 84 C3G (82%), and 85 I3L (81%). Silent
hanges are seen at amino acids 32 (91%), 38 (90%), 41
83%), 51 (62%), 63 (83%), and 65 (82%) (Fig. 1).
Six samples, NPC 1, 7, 19, 24, 27, and 29a, represented
he China 2 strain (Sung et al., 1998), which includes
hanges at the following bp in over 83% of the isolates
Fig. 1): 169467, 169437, 169425, 169402, 169400, 169379,
69378, 169361, 169339, 169322, 169306, 169295, 169286,
69280, 169276, 169274, 169225, and 169222. Less fre-
uent changes (.67%) were detected at bp 169348 and
69230 (Fig. 1). These changes lead to amino acid
hanges at positions 3 H3R (67%), 13 R3P (67%), 17
3L (100%), 25 L3M (100%), 33 L3I (100%), 43 V3I
67%), 46 D3N (100%), 57 S3A (83%), 67 D3H (100%),
2 A3G (67%), 84 C3G (100%), and 85 I3L (100%).
FIG. 1. Sequence variation in the amino-terminal portion of LMP1. Num
n the left column refer to the individual isolates. A plus sign indicates va
equence beyond this point is unknown; and a dash indicates a deletio
nd arranged by groups.ilent changes occur at amino acids 32 (100%), 38
100%), 51 (100%), 60 (83%), 63 (100%), and 65 (100%). The
hina 2 strain shares many changes with the China 1
train on the amino-terminus, but the methionine at po-
ition 25 and isoleucine at position 33 are unique to this
train and, as previously shown, perfectly discriminate
etween the China 1 and China 2 strains (Sung et al.,
998).
Two samples, NPC 60 and Par 1 (parotid tumor), were
f a third pattern, the Alaskan strain (Miller et al., 1994;
ung et al., 1998), which includes bp changes at posi-
ions 169647, 169437, 169425, 169411, 169402, 169379,
69361, 169352, 169348, 169339, 169331, 169306, 169288,
69286, 169280, 169276, 169274, 169230, 169225, and
69222 (Fig. 1). In the Alaskan strain, these bp changes
ead to amino acid changes at positions 3 H3R, 13 R3P,
7 R3L, 22 S3P, 25 L3I, 43 V3I, 46 D3N, 57 S3A, 63
3V, 67 D3H, 82 A3G, 84 C3G, and 85 I3L, with silent
hanges at amino acids 32, 38, 41, 48, and 65. The
laskan strain also shares many changes with both the
hina 1 and China 2 strains, but the proline at position 22
nd the valine at amino acid 63 are unique to this strain,
nd these two positions have been shown to discrimi-
ate this strain from the China 1 and China 2 strains
Sung et al., 1998).
The Raji cell line and HLP 9 have multiple changes in
ommon with the Alaskan strain with changes at 169467,
69466, 169402, 169379, 169348, 169306, 169288, 169286,
nd 169280 (Fig. 1). These bp changes correspond to
mino acid changes at positions 3 H3L, 25 L3I, 43
3I, 57 S3A, and 63 I3V and silent changes at posi-
ions 32 and 65. Raji also has bp changes at 169469,
69339, and 169222 leading to amino acid changes of 2
3D, 46 D3N, and 85 I3L. The Raji and HLP 9 samples
ave the valine at position 63 but lack the proline at
osition 22, changes that are characteristic of the Alas-
an strain.
A pattern designated as the Mediterranean pattern,
ed, was detected in 12 samples, including those from
PCs C15, 53, 54, and 57; cell lines AG876, P3HR1, and
91; Mono 1 (mononucleosis); BL 1; and PTL 2 and HLPs
0 and 11. This strain has few changes in the amino-
erminus but is marked by bp changes at 169339 and
69222 (Fig. 1). These bp changes result in amino acid
hanges at positions 46 D3N (40%) and 85 I3L (100%)
Fig. 1). The leucine at position 85 is also found in the
laskan, China 1, and China 2 strains, but the leucine at
osition 85 in the absence of the other multiple changes
s indicative of the Med strain.
Two samples, PTL 1 and Mono 2, had a fifth pattern,
cross the top row correspond to the EBV genome coordinates; names
from the B95-8 prototype strain at this locus; a question mark indicates
s locus. The strain identifying changes are in bold, shaded, patterned,bers a
riation
n at thi
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82 EDWARDS, SEILLIER-MOISEIWITSCH, AND RAAB-TRAUBhe NC strain, which includes consistent bp changes at
ositions 169460, 169425, 169423, 169402, 169400,
69398, 169379, 169366, 169364, 169361, 169352, 169348,
69347, 169339, 169322, 169286, 169276, 169274, 169225,
nd 169222 (Fig. 1). These bp changes result in amino
cid changes at positions 17 R3L, 18 G3R or G3Q, 25
3I, 26 G3I, 37 L3I, 43 V3T, 46 D3N, 67 D3H, 84
3G, and 85 I3L. Silent changes are found at amino
cids 5, 32, 38, 41, 51, and 63. The amino acid changes to
soleucine at position 37 and threonine at 43 are unique
o this strain. Interestingly, this strain shares the change
o an isoleucine at position 25 with the China 1 and
laskan strains, but this change is due to an additional
nique bp change at position 169400.
The remaining 13 isolates from NPCs 4, 6, 8, 9, 18,
0–32, 35, 42, 45, 55, and 56 had few if any changes and
ere considered of the B95-8 pattern or strain (Fig. 1).
Several of the sequence changes on the amino-termi-
us are shared among the different sequence patterns,
ut most are also marked by additional changes that are
nique to each group (Fig. 1).
nalysis of the LMP1 carboxyl-terminus and
dentification of strains
Eighty-three sequence samples from EBV coordinates
68755–168163 were obtained from 45 of the tissue
pecimens, and these were compared with the B95-8
rototype strain. Seven definitive patterns were identified
sequences not shown). The China 1 pattern (Miller et al.,
994; Sung et al., 1998) was detected in 24 samples,
ncluding NPCs 13, 17, 23, 31, 36a, 38a, 38b, 38c, 39, Cao,
510; N 1a (normal); HLPs 1, 2a, 2b, 2c, 2d, 2e, 2f, 3a, 4a,
a, and 9; and PT 1a (post-transplant with no post-
ransplant lymphoproliferative disease). The China 1
train had 11 changes from B95-8, at positions 168687
3A, 1688631 A3G, 168395 G3A, 168357 C3A,
68355 A3T, 168320 A3G, 168308 T3C, 168225 T3A,
nd the 30-bp deletion in .87% of the isolates, with less
requent changes (.52%) at bp 168694 T3C and 168295
3T. These bp changes correspond to amino acid
hanges at positions 212 G3S, 309 S3N, 322 Q3N or
3K, 334 Q3R, 338 L3S, and 366 S3T and the dele-
ion of amino acids 343–352, with silent changes at
mino acids 209, 230, and 342 (Fig. 2). The amino acid
hanges at 212, 309, 322, 334, 338, and 366 and the
eletion of 343–352 were most strongly correlated
.87%) with this strain, with the asparagine at position
22 unique to this strain.
The China 2 pattern (Sung et al., 1998) was detected in
FIG. 2. Amino acid variation in the carboxyl-terminal portion of LMP1.
hich the B95-8 prototype amino acid sequence is listed. The position
o the individual isolates, changes in the amino acids are denoted by
nknown, and a dash indicates a deletion of this amino acid. The strain identif7 samples, including NPCs 1, 14, 15, 19, 24, 25, 27, 29a,
6b; HLPs 5c, 5d, 5e, 5f, 5g; and PTs 1d, 1e, and 1f. The
hina 2 strain had changes at positions 168687 G3A,
68587 C3A, 168395 G3A, 168361 T3G, 168330 G3C,
68329 G3A, 168309 T3C, 168308 T3C, 168295 A3T,
68290 G3A, and 168225 T3A in .88% of the isolates,
ith less frequent changes (.70%) at bp 168694 T3C,
68566 G3A, and 168257 G3C. These bp changes lead
o amino acid changes at positions 212 G3S, 245 P3H,
52 G3D, 309 S3N, 331 G3Q, 338 L3P, 344 G3D, 355
3A or G3T, and 366 S3T, with silent changes at 209,
20, and 342 (Fig. 2). The changes at amino acids 212,
45, 252, 309, 331, 338, 344, and 366 strongly correlated
.82%) with this strain. The histidine at position 245 and
he aspartic acids at positions 252 and 344 are unique to
he China 2 strain.
The Med pattern was detected in 18 samples, includ-
ng NPCs 56, C15, C17, C18, and C19; HLPs 2g, 3b, 3c, 5b,
a, 6b, 6c, 7, and 11; N 1b and 1c; and cell line W91. The
ed strain had changes at 168395 G3A, 168357 C3G,
68266 A3G or the 30-bp deletion, and 168225 T3A or
in .88% of the isolates, with less frequent changes
.69%) at bp 168635 G3C, 168320 A3G, 168308 T3C,
68295 A3T, 168238 G3A or C. These bp changes
orrespond to amino acid changes at positions 229 S3T,
09 S3N, 322 Q3E, 334 Q3R, 338 L3S, 352 H3R or
eleted, and 366 S3N or T or A, with silent changes at
mino acids 342 and 361 (Fig. 2). The amino acid
hanges at positions 229, 309, 322, 334, 338, 352 or
eletion, and 366 delineated this strain, with the glutamic
cid at 322 being unique to this strain.
Two samples, NPCs 16 and 29b, were very similar to
he China 1 and Med strains. This China 3 strain had bp
hanges at positions 168694 T3C, 168687 G3A, 168631
3G, 168308 T3C, 168295 A3T, the 30-bp deletion,
nd 168225 T3A. The corresponding amino acid
hanges were 212 G3S, 338 L3S, 366 S3T, and the
eletion of 343–352 (Fig. 2). Silent changes were found at
mino acids 209, 230, and 342.
The Alaskan strain (Miller et al., 1994; Sung et al., 1998)
as detected in three samples, including NPC 60, HLP
b, and Par 1. This strain had changes at positions
68694 T3C, 168687 G3A, 168640 C3T, 168387 G3A,
68384 T3G, 168357 C3A, 168329 G3C, and the ab-
ence of the 30-bp deletion in all the isolates, with less
requent changes (.66%) at bp 168626 G3C, 168395
3A, 168309 T3C, 168308 T3C, 168295 A3T, 168288
3A, 168260 G3A, and 168257 G3T. These bp
hanges correspond to amino acid changes at positions
rs across the top correspond to the LMP1 amino acid positions under
3-bp repeats is denoted across the top, names in the left column refer
er changes, a question mark indicates sequence beyond this point isNumbe
of the 3
the lettying changes are in bold, shaded, patterned, and arranged by groups.
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84 EDWARDS, SEILLIER-MOISEIWITSCH, AND RAAB-TRAUB12 G3S, 232 G3A, 309 S3N, 312 D3N, 313 S3A, 322
3K, 331 G3A, 338 L3P, 345 G3S, 354 G3D, and 355
3V, with silent changes at 209, 227, and 342 (Fig. 2).
he Alaskan strain had distinct changes from the other
trains, notably the changes of amino acids to alanine at
32, asparagine at 312, alanine at 313, lysine at 322,
lanine at 331, serine at 345, aspartic acid at 354, and
aline at 355.
The sixth pattern, the NC strain, was detected in two
amples: PTL 1 and Mono 2. This strain had consistent
utations at positions 168404 T3A, 168395 G3A,
68384 T3C, 168357 C3A, 168356 A3C, 168330 G3C,
68329 G3A, 168309 T3C, 168308 T3C, 168295 A3T,
68267 C3A, 168248 A3C, and the absence of the
0-bp deletion. These mutations resulted in amino acid
hanges at positions 306 L3Q, 309 S3N, 313 S3P, 322
3T, 331 G3Q, 338 L3P, 352 H3N, and 358 H3P with
silent change at 342 (Fig. 2). This strain also had
istinct changes from the other strains with a glutamine
ound at amino acid position 306, a proline 313, a thre-
nine 322, an asparagine at 352, and a proline at 358.
Another 13 samples had sequence nearly identical to
hat of the B95-8 strain. These included the cell lines Raji
nd P3HR1; PTs 1b, 1c, and 2; N 1d; and HLPs 2h, 3e, 3f,
a, 8b, 8c, and 8d. These samples had sporadic bp
hanges, but consistent changes were not identified
Fig. 2).
Several of the sequence samples, including those
rom Mono 1, AG876, HLP 3d, and HLP 4c, had sequence
atterns suggestive of interstrain recombination and are
iscussed later.
Several of the bp changes were common to the differ-
nt strains, including the silent change of a T3C at
68694 and a G3A at 168687 in the China 1, China 2,
hina 3, and Alaskan strains. The change of G3A at
68395, a T3C at 168308, and a T3A at 168225 was
ound in all strains with the exception of the B95-8 strain.
istinct changes in the glutamine at position 322 were
dentified in four of the strains, with an asparagine found
n China 1, a glutamic acid in Med, a lysine in Alaskan,
nd a threonine in NC (Fig. 2). This amino acid change
as fairly diagnostic of the strain.
nalysis of the full-length LMP1 and identification of
trains
The sequence of both the amino and carboxyl do-
ains was determined in 29 samples. The same strain
FIG. 3. Identification of strains of EBV by amino acid patterns in LMP
n the full-length LMP1. Numbers across the top correspond to the LMP1
s listed. The position of the 33-bp repeats is denoted across the top, na
re denoted by the letter changes, a question mark indicates sequence
train identifying amino acid changes are in bold and characteristica
dentifying pattern and shading. (B) Phylogenetic tree drawn from the ca
odel with two parameters at each position (Felsenstein, 1995) and theroup according to strain, and the strains are denoted by shading with the reas detected in the majority of these samples in both the
mino- and carboxyl-termini. China 2 was identified in
PCs 1, 19, 24, 27, and 29a; China 1 in NPCs 13, 17, 23,
6a, 39, 1510 and Cao and HLP 2a; the Med strain in NPC
15, HLP 11, and cell line W91; the NC strain in PTL 1 and
ono 2; and the Alaskan strain in NPC 60 and Par 1 (Fig.
A). NPCs 36a and 2a were the China 1 strain on the
arboxyl-terminus, but because they lacked some of the
haracteristic changes in the amino-terminus, they were
ore distantly related (Fig. 3A). Nine samples, Mono 1,
aji, AG876, P3HR1, NPC 16, NPC 31, NPC 36b, and NPC
6, and HLP 9, are discussed in the section on recom-
ination.
nterstrain recombination
Several of the samples analyzed had amino acid
hanges characteristic of more than one strain. The
3-bp repeats in the carboxyl-terminus have been sug-
ested as a site for recombination (Miller et al., 1994).
nalysis of the carboxyl-terminal sequence revealed that
LP 4c had the threonine at 229 characteristic of the
ed strain on one side of the repeats and some of the
laskan changes on the other side of the repeats, sug-
esting that this isolate was a product of interstrain
ecombination (Fig. 2). This is particularly likely as this
train was identified in an HLP where lytic viral replica-
ion and recombination have been previously described
nd frequently occur (Walling and Raab-Traub, 1994).
imilarly, HLP 3d had the characteristic threonine at 229
f the Med strain but was marked by the China 1
hanges on the distal side of the repeats, in particular,
he characteristic asparagine at amino acid 322 (Fig. 2).
n those samples with both amino- and carboxyl-terminal
equences, NPC 31 (Sung et al., 1998) resembles B95-8
n the amino-terminus and the China 1 in the carboxyl-
erminus, suggesting that it also arose from recombina-
ion across the repeats (Fig. 3A). Two samples, NPC 36a
nd NPC 36b, were identified in an NPC specimen that
as clonal by the termini assay (data not shown) (Raab-
raub and Flynn, 1986). NPC 36a is China 1 in both the
mino- and carboxyl-termini, whereas NPC 36b has
hina 1 characteristic changes in the amino-terminus
ith China 2 characteristic changes in the carboxyl-
erminus distal to the 33-bp repeats (Fig. 3A). This re-
ombinant may have developed in the individual or may
ave been transmitted. NPC 56 appears to have resulted
rom a B95-8/Med strain recombination, whereas P3HR1
by phylogenetic analysis of LMP1 sequence. (A) Amino acid variation
acid positions under which the B95-8 prototype amino acid sequence
the left column refer to individual isolates, changes in the amino acids
point is unknown, and a dash indicates a deletion of this amino acid.
ed. Recombinant isolates can be identified by more than one strain
terminal nucleotide sequence of the samples using the site-dependent
or-joining method (Saitou and Nei, 1987). The isolates characteristically1 and
amino
mes in
at this
lly shad
rboxyl-
neighbcombinants denoted by double shading.
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86 EDWARDS, SEILLIER-MOISEIWITSCH, AND RAAB-TRAUBs a Med/B95-8 recombinant, and AG876 is a Med/China
strain recombinant (Fig. 3A). NPC 16 had all the char-
cteristic China 1 changes on the amino-terminus and
he China 3 characteristic changes on the carboxyl-
erminus, resulting in a recombinant strain, a China
/China 3 strain (Fig. 3A). The Raji cell line shares many
f the Alaskan strain changes in the amino-terminus but
esembles the B95-8 strain in the carboxyl-terminus, sug-
esting that it also arose from recombination (Fig. 3A).
LP 9 appears to be an Alaskan/China 1 recombinant
Fig. 3A). Mono 1 appears to be a double recombinant
ith Med characteristic changes in the amino- and distal
arboxyl-termini and B95-8 characteristics in the inter-
ening sequences resulting in a Med/B95-8/Med recom-
inant (Fig. 3A).
hylogenetic analysis of the viral nucleotide
equences
To strengthen the classification of the above patterns
s true strains and to determine the phylogenetic rela-
ionships between the EBV isolates from the various
isease states and geographic locations, the DNA se-
uences from the amino-terminus, carboxyl-terminus,
nd a fusion of the amino- and carboxyl-termini were
nalyzed. Distance matrices were calculated using the
ne-parameter model (Jukes and Cantor, 1969), in which
he rate of substitution is equal between all nucleotides;
he Kimura (1983) two-parameter model, which assumes
hat transition-type changes are more likely to occur than
ransversion-type changes (in these isolates, this ratio is
.3:1); and the model, which allows different Kimura pa-
ameters at each position (Felsenstein, 1995). From
hese distances, phylogenetic trees were inferred using
he neighbor-joining (Saitou and Nei, 1987) and UGMA
Nei, 1975) methods. The latter assumes a molecular
lock (i.e., a constant rate of evolution among lineages).
he tree presented (Fig. 3B) was reconstructed using the
odel that allows different parameters at each position
nd the neighbor-joining method, but all methods pro-
uced trees with similar branching patterns (data not
hown).
The trees based on the amino-terminus did not clearly
istinguish all the strains, but isolates of strains China 2,
laskan, and NC were consistently grouped, suggesting
hat the distinguishing sequence patterns in these
trains in the amino-terminus reflect their phylogenetic
elationship (tree not shown). The variability in the China
strain made it difficult to form a single cluster.
The carboxyl-terminal sequences consistently pro-
uced trees of similar groupings, suggesting the
trength of the changes in the carboxyl-terminus for
lassifying and distinguishing the strains. These trees
evealed multiple branches with the seven identified
equence patterns usually clustering within a branch or
etween two closely related branches (Fig. 3B). Several sf the China 1 isolates, notably HLPs 1 and 9, PT 1a, N
a, NPCs 36a, and NPC 1510 are positioned slightly away
rom the majority due to the absence of the silent change
t amino acid 209 in HLP 1 and 9, PT 1a, and NPC 36a,
nd common T at position 192 in N 1a, NPC 36a, and
PC 1510 (Figs. 2 and 3B). In all phylogenetic reconstruc-
ions, these samples consistently are grouped with the
hina 1 strain (data not shown). Also, HLP 5a, which has
ost of the China 1 changes, is positioned close to sister
solate HLP 5b due to the R shared at position 243 (Figs.
and 3B). Several of the Med isolates, notably NPCs
15, C18, and C19, N 1c, and HLPs 3b, 3c, and 11, also
luster down from the majority of the Med isolates in the
ree presented here due to the presence of the Gs in the
epeat region (Figs. 2 and 3B), but these samples also
onsistently grouped with the Med strain in all trees
data not shown).
These trees also reveal the degree of relatedness of
he seven strains, with the China 1 and Med strains
losely related and positioned off the same branch and
he China 3 strain closely related to both these strains.
he NC and Alaskan strains are closely related and
omewhat related to the China 2 strain (Fig. 3B). The
rees derived from the full-length sequences showed the
ame consistent groupings and thus strengthen the clas-
ification of these patterns as true strains (tree not
hown).
lassification of strains based on amino acid
ignature patterns
Because distinct sequence patterns (strains) were de-
ected and the strains consistently grouped from the
rees of the carboxyl-terminal sequence, the CART meth-
dology was applied to determine the amino acid posi-
ions that could characterize them. Twenty-six samples
ver full-length sequence was analyzed (48 variable po-
itions), 58 samples over the amino-terminus (16 variable
ositions), and 53 samples over the carboxyl-terminus
44 variable positions). Perfect discrimination between
he strains was found only when the carboxyl-terminal
equences were analyzed and only for the phylogenetic
ree groupings (strains), compared with disease or geo-
raphic location groupings.
The seven phylogenetically defined strains could be
erfectly discriminated over seven loci in the carboxyl-
erminus (Table 1). A substitution of an aspartic acid for
he glycine at amino acid 344 perfectly classifies the
hina 2 strain (Table 1). The China 1 strain can be
lassified by a serine at position 229, a substitution of an
rginine for the glutamine at amino acid 334, and the
eletion of 344 (Table 1). The Med strain can be discrim-
nated from the other strains by the presence of a thre-
nine at 229, a glutamic acid at 322, and either a glycine
r the deletion of amino acid 344 (Table 1). The China 3
train can be distinguished by a serine at 229, a glu-
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87AMINO ACID CHANGES IN LMP1 DISTINGUISH EBVamine at 322, a glutamine at 334, a serine at 338, and
he deletion of amino acid 344 (Table 1). The Alaskan
train has a serine at 229, an asparagine at 312, a lysine
t 322, a glutamine at 334, and a glycine at 344 (Table 1).
he NC strain can be classified by a serine at 229, a
lutamine at 306, an aspartic acid at 312, threonine at
22, a glutamine at 334, and a glycine at 344 (Table 1).
hese changes are all in comparison with the B95-8
rototype strain, and members of the B95-8 strain do not
ave changes at these seven loci (Table 1). Additional
mino acid changes occurred that were always present
n some of the strains, in addition to the discriminating
oci. The Alaskan strain is marked by an alanine at both
13 and 331. The NC strain has a proline at 313, an
sparagine at 352, and a proline at amino acid 358.
hen the discriminating amino acid 344 was deleted
rom the isolates and the CART analysis redone, perfect
iscrimination between the seven strains was still seen
ver six loci, amino acid positions 306, 312, 322, 331, 334,
nd 338, further supporting the designation of the above
even sequence patterns as true strains.
When the CART methodology was applied with the
TABLE 1
Amino Acid Positions in the C-Terminus, as Determined by CART
Analysis, of LMP1 That Discriminate Among the Seven EBV Strains
Strain Locus Amino acid
China 1 229 Ser
334 Gln to Arg
344 Deleted
China 2 344 Gly to Asp
Med 229 Ser to Thr
322 Gln to Glu
344 Gly or deleted
China 3 229 Ser
322 Gln
334 Gln
338 Leu to Ser
344 Deleted
Alaskan 229 Ser
312 Asp to Asn
322 Gln to Lys
334 Gln
344 Gly
NC 229 Ser
306 Leu to Gln
312 Asp
322 Gln to Thr
334 Gln
344 Gly
B95-8 229 Ser
306 Leu
312 Asp
322 Gln
334 Gln
338 Leu
344 Glyamples grouped by disease or geographic location, perfect discrimination was not found. This indicates that
trains or specific amino acid changes did not perfectly
orrelate to a specific disease state or geographic loca-
ion. However, some strains, as determined by the car-
oxyl-terminal sequence only, were more prevalent in
ertain populations. In the Asian samples, 63% were
hina 1, 12% were China 2, 3% were China 3, and 17%
ere B95-8 strains. Among the Mediterranean and Afri-
an samples, 90% were Med and 10% were B95-8. The
.S. samples were 23% China 1, 12% China 2, 31% Med,
% Alaskan, 8% NC, and 23% B95-8 strains. Both Alaskan
amples were the Alaskan strain, and the sole European
ample belonged to the B95-8 strain.
rror rate of viral DNA polymerase versus host DNA
olymerase
In latent infection, the EBV genome is replicated by the
ost DNA polymerase, whereas in permissive infection,
BV DNA is replicated by the viral DNA polymerase. HLP
s the only example of a permissive EBV infection and is
esponsive to inhibitors of the viral DNA polymerase,
uch as acyclovir (Resnick et al., 1990). Several of the
trains were found in examples of latent (NPC, N, PT, and
L) and permissive (HLP) infection. This finding allows
or a comparison of the relative error rate of the host and
iral polymerases. The error rate of Taq polymerase is
0.001% (Eckert and Kunkel, 1990) and therefore did not
ignificantly affect the analysis of the data. By analyzing
he 592 nucleotides within the carboxyl-terminal se-
uence, the mean error rate was calculated for each
olymerase by totaling the number of changes outside
he signature from all representatives of either latent or
ermissive infection of a given strain and dividing by the
otal number of nucleotides. In the case of more than one
ample of the same strain from a given specimen, the
ample with the greatest number of changes outside the
ignature was used. This relative rate does not reflect
he actual error rate of the polymerases, as the bp
hanges represent the accumulated changes after mul-
iple cycles of replication, and other viral or cellular
roteins may contribute to replication fidelity. A total of
ine samples of the China 1 strain were obtained from
atent infections, where the viral genome is replicated by
he host polymerase, and had an estimated error rate of
.64%. The five China 1 samples from permissive infec-
ions had an error rate of 0.71% (Table 2). In the China 2
train, the host polymerase had an error rate of 0.64%,
nd the viral polymerase had an error rate of 0.68%
Table 2). Similar error rates between the host and viral
olymerases were also identified in the Med strain with
ates of 1.08% and 0.98%, respectively (Table 2). The
95-8 strain had the greatest difference in the error
ates, with the viral polymerase error rate of 1.2% and the
ost polymerase error rate of 0.71% (Table 2). To com-
are the error rate of host versus viral polymerase, a
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88 EDWARDS, SEILLIER-MOISEIWITSCH, AND RAAB-TRAUBinomial test for the difference in proportion was used.
he P values were generated for each strain, comparing
he proportion of changes outside the signature for latent
nfection against that for permissive infection. All strains
ad a value of P . 0.05, indicating no significant differ-
nce between the error rates during latent or permissive
nfection.
DISCUSSION
In this study, the DNA sequence variation in LMP1 of
BV isolates was analyzed and strains were identified
ased on these sequence patterns and on the phyloge-
etic trees. EBV strains have been previously distin-
uished by loss of XhoI cut site (Abdel-Hamid et al.,
992), the presence of a 30-bp deletion, and sequence
ariation in the amino-terminus of LMP1 (Miller et al.,
994; Sung et al., 1998). The data presented here indicate
hat these changes do not perfectly discriminate be-
ween the strains. The China 1, China 3, and Med strains
ll have the deletion, whereas China 1, China 2, Alaskan,
nd NC strains all have lost the XhoI cut site. However,
he unique and numerous changes in the amino-termi-
us of the China 2, Alaskan, and NC strains do consis-
ently group in the phylogenetic analysis, supporting
heir classification as strains. The China 1 strain had the
reatest variability in the amino-terminus but was con-
istently marked by the change of a leucine to isoleucine
t amino acid position 25, as previously noted (Sung et
l., 1998).
The carboxyl-terminal sequence of LMP1 distin-
uished seven distinct sequence patterns or strains.
hese seven strains consistently associated in all trees,
trengthening their classification as true strains. These
trains can be perfectly discriminated over seven loci, at
mino acids 229, 306, 312, 322, 334, 338, and 344. The
hange at amino acid 322 is particularly informative with
n asparagine present in China 1, a glutamic acid in
ed, a lysine in Alaskan, a threonine in NC, and a
T
Error Rate of Host versus Viral Polymerase and the Resulting P
omparing the Proportion of Changes Outside the Signature for La
olymerase) of a Given Strain
Strain
Type of infection
(polymerase)
No. of total
isolates
hina 1 Latent (host) 9
Permissive (viral) 5
hina 2 Latent (host) 10
Permissive (viral) 1
ed Latent (host) 7
Permissive (viral) 5
95-8 Latent (host) 5
Permissive (viral) 3lutamine in B95-8, China 2, or China 3 strains. A similar analysis of newly discovered Kaposi sarcoma-associ-
ted herpesvirus revealed that there were three distinct
trains marked by signature bp changes (Zong et al.,
997).
Two NF-kB-activating regions have been identified
ithin the carboxyl-terminus of LMP1 (Huen et al., 1995)
ocated at amino acid positions 187–231, CTAR1, and
51–386, CTAR2. A conservative change occurs in
TAR1 with the change of the serine to threonine in the
ed and China 2 strains at amino acid 229. An additional
hange occurs in CTAR1 with the change from a glycine
o a serine in amino acid 212 in the China 1, China 3,
hina 2, and Alaskan strains. Nonconservative changes
ere also identified in several isolates. Three China 2
solates have a glutamine, and Raji and HLP 1 have an
sparagine in place of the histidine at amino acid 213.
aji, W91, and HLP 1 have a glutamine replacing a
lutamic acid at position 214. Five China 2 isolates have
glycine instead of an arginine at amino acid 223. Raji
nd NPC 29 also have a leucine in place of histidine at
mino acid 225. In the distal region, CTAR2, all strains
ith the exception of B95-8 show the conservative
hange of a serine to threonine or alanine at amino acid
66. The NC strain shows nonconservative changes at
mino acid 352, a histidine to asparagine, and amino
cid 358, a histidine to proline. The Alaskan strain has
onconservative changes at amino acids 354, glycine to
spartic acid, and 355, glycine to valine. In 12 of 17 China
isolates, a nonconservative change at position 355 is
een: glycine to alanine or threonine.
Within the two NF-kB-activating domains, two critical
otifs have been identified that bind the tumor necrosis
eceptor-associated factors, TRAF and TRADD. The PX-
XT motif at amino acids 204–208, which directly binds
he TRAFs 1, 2, 3, and 5 (Mosialos et al., 1995) and
nduces epidermal growth factor receptor expression
Miller et al., 1997), is unchanged in all 84 isolates except
LP 3e, which has amino acid 207 changed from an
Generated Using a Binomial Test for the Difference in Proportion
fection (Host Polymerase) with That for Permissive Infection (Viral
tal No. of changes outside
ture/total No. of nucleotides Mean error P
34/5328 0.64% 0.3522
21/2960 0.71%
38/5920 0.64% 0.4602
4/592 0.68%
45/4144 1.08% 0.3306
29/2960 0.98%
21/2960 0.71% 0.0570
21/1776 1.2%ABLE 2
Values
tent In
To
signalanine to a valine. Also, the PXQXS motif at amino acids
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89AMINO ACID CHANGES IN LMP1 DISTINGUISH EBV79–383, which binds the TRADD adapter protein, is
onserved in all isolates, further strengthening the im-
ortance of TRAF signaling to LMP1 function. Interest-
ngly, an additional PXQXT motif at amino acids 320–324,
utside CTAR1 and CTAR2, is altered in the China 1, Med,
laskan, and NC strains with mutation of the critical Q at
22, suggesting that this motif is not essential to LMP1
unction. The LMP1 sequences in both the baboon and
hesus EBV-related lymphotropic herpesviruses are quite
ivergent from EBV LMP1 but retain homologous TRAF-
nteracting regions. Rhesus EBV contains five potential
RAF-binding motifs, although it is unknown whether all
f them are essential for LMP1 function (Franken et al.,
996). In EBV LMP1, the PHDPLP motif located from
mino acids 302–307 has been suggested to bind the
AK 3 kinase (Gires et al., submitted for publication) and
s conserved in five of the strains; however, the amino
cid 306 is changed to a proline in the Alaskan strain and
o a glutamine in the NC strain. It is unknown whether
hese mutations would affect the activation of the JAK/
TAT pathway.
The 30-bp deletion of amino acids 343–352 has been
roposed to occur during replication through homolo-
ous recombination between duplicated sequences, bp
68256–168265 and bp 168295–168286, which flank the
eleted region (Sandvej et al., 1994; Sung et al., 1998). In
ome of the samples of the China 1, Med, and China 3
trains, the repeat region is extended by the change of
n A to a T at 168295, possibly facilitating the deletion of
he sequences (Sung et al., 1998). However, a parental
orm of the China 1 strain, lacking the 30-bp deletion,
as not identified, suggesting that the deleted form has
ompletely replaced the putative original strain. Only in
he Med strain were both deleted and undeleted forms
etected, suggesting that the deletion does develop from
n undeleted parental strain. A recent study that used
MP1 sequence variation to track EBV strain prevalence
n long-term HIV infection did identify isolates that ap-
eared to be China 1 strains that were undeleted (Berger
t al., 1999). This study found no correlation between the
resence of the 30-bp deletion and the development of
IDS-NHL. The China 2 strain has changes at bp 168290
nd 168257 within these duplicated sequences, which
pparently hinder recombination, hence preventing the
eletion of the intervening 30 bp (Sung et al., 1998). The
laskan strain has changes at 168288 and 168260 that
lso disrupt the homology and inhibit the deletion. The
reviously described isolate with the 69-bp deletion
Larcher et al., 1997) does not have homologous se-
uences flanking the deletion, so it is uncertain how this
eletion occurred.
The large number of samples representing both latent
nd permissive infection also allowed for the compari-
on of host and viral polymerase error rates. The calcu-
ated error rate, based on changes outside of the signa-
ure amino acid changes, suggests that the EBV DNA molymerase has fidelity comparable to that of the host
NA polymerase. The fact that the viral polymerase can
aintain DNA fidelity in HLP with its fulminant lytic viral
eplication is noteworthy. The high fidelity of the viral
olymerase is also indicated by the remarkable conser-
ation of the signature amino acids that distinguish the
trains and the rare occurrence of additional bp changes
ithin strains. Similarly, with each of the Kaposi sarco-
a-associated herpesvirus strains, there are very few bp
hanges outside the signature sequences (Zong et al.,
997).
Interstrain recombination in the EBNA2 gene has been
dentified in EBV isolates from the permissive infection in
LP (Walling and Raab-Traub, 1994). The carboxyl-termi-
us of LMP1 contains an 11-amino-acid repeat region,
odons 250–308, of varying copy number through which
nterstrain recombination could occur (Miller et al., 1994).
he identification of multiple EBV strains suggests that
ome isolates have arisen from recombination. Eleven
amples identified in this study appear to result from
ecombination, seven of which may have occurred from
ecombination across the repeat region: HLP 4c, HLP 3d,
LP 9, NPC 31, NPC 36b, NPC 16, P3HR1, and AG876.
nterestingly, NPC 36a and 36b have the same amino-
erminal sequence but distinct carboxyl sequences. The
ther three samples, Mono 1, NPC 56, and Raji, appar-
ntly result from recombination outside of the repeat
egion, confirming a previous suggestion that recombi-
ation can occur within unique sequences (Sung et al.,
998).
Importantly, these same seven strains can be identi-
ied in most of the published sequences of additional
solates. However, it is likely that this is an underrepre-
entation of the possible LMP1 sequences and that other
trains exist. A recent study of EBV strain variation in
LP identified multiple potential substrains and novel
ecombinant strains (Walling, et al., 1999). The only strain
reviously described but not identified in this study was
strain with a 69-bp deletion (Larcher, et al., 1997). This
arger deletion seems to have occurred in a Med strain
ecause it has the characteristic threonine at 229. The
act that the China 3 strain was detected in only two
solates in this study suggests that it may represent a
ery rare strain or may be a possible double recombi-
ant, a China 1/B95-8/China 1 strain, notably because
he single China 3 isolate with full-length sequence, NPC
6, had all the characteristic China 1 changes on the
mino-terminus. Based on the carboxyl-terminal se-
uence patterns, the China 1 strain appears to be the
ost prevalent and is detected in both normal tissues
nd pathologies in Europe, America, and Asia (Table 3A).
mong European isolates, the China 1, Med, B95-8, and
C strains were identified in normal tissue specimens;
95-8, NC, Med, and China 1 strains were identified in
odgkin’s disease specimens; isolates from infectious
ononucleosis were B95-8, NC, China 1, or Med strains;
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90 EDWARDS, SEILLIER-MOISEIWITSCH, AND RAAB-TRAUBeripheral T cell lymphoma specimens had B95-8, Med,
r China 1 strains; lymphoproliferative disease speci-
ens had China 1, B95-8, or Med strains; tonsillar hyper-
lasia specimens had B95-8 or China 1 strains, and
ngioimmunoblastic lymphadenopathy specimens had
hina 1 or Med strains (Knecht et al., 1993, 1995a,b;
andvej et al., 1994, 1997; Berger et al., 1997). Among
mericans, infectious mononucleosis specimens could
e categorized as having B95-8, Med, China 1, or China
strains; HLP as having China 1; and post-transplant
ymphoproliferative disease specimens as having China
, B95-8, Med, or NC strains (Palefsky et al., 1996; Smir et
l., 1996; Berger et al., 1997). Among Asian isolates, the
hina 1 and B95-8 strains were found in normal speci-
ens; the China 1, China 2, and B95-8 strains in infec-
ious mononucleosis specimens; the China 1 and China
strains in chronic EBV specimens; the China 1 and
hina 2 strains in carcinomas; the China 1, China 2, and
ed strains in lymphomas; the China 1 and China 2
trains in gastric tumors; the China 1 and China 2 strains
n NPC; and the China 1 and B95-8 strains in peripheral
cell lymphomas (Sandvej et al., 1994; Chang et al.,
995; Cheung et al., 1996; Itakura et al., 1996; Leung et
l., 1997). Table 3B shows the combined incidence of the
trains (based solely on the carboxyl-terminal sequence)
n the various disease states from the data presented in
his study and the others previously cited. Although it is
nclear in this survey whether the disease distribution of
he strains corresponds to the geographic prevalence of
hat strain in that population, all strains have pathological
otential (Tables 3A and 3B). In some instances, one
train appears to be more prevalent in a disease than in
he normal population, and an exact test for indepen-
ence between strains and diseases was performed and
values calculated using a Monte-Carlo procedure for
he Asian, European, and U.S. isolates. In these three
ases, a significant correlation between disease and
train was not found, as the calculated P values were
0.05 (data not shown). However, these suggestions will
ave to be further investigated due to the nonrandom
ampling and the low number of normal samples in this
TA
Geographic and Disease
China 1 China 2
sia (297 isolates) 86% 8%
ed 1 Africa (10 isolates)
urope (111 isolates) 45%
S (83 isolates) 45% 5%
laska (2 isolates)
Note. Geographic distribution of the seven EBV strains (as determine
nd others cited in the discussion (423 published samples that were
erminus).nalysis. tThe identification of strains also allows for the identi-
ication of samples that contain more than one strain.
LPs have been shown to harbor more than one strain
hrough EBNA typing (Walling and Raab-Traub, 1994) and
ecently through analysis of the LMP1 sequence (Walling
t al., 1999). HLP 2 and HLP 3 contain China 1, Med, and
95-8 strains. HLP 4 contains China 1, Alaskan, and
ed/Al strains. The presence of the recombinant strain
ed/Al could indicate that in this HLP, a Med strain was
resent that was not captured for analysis. HLP 5 has
hina 1, Med, and China 2 strains. Interestingly, three
trains, China 1, B95-8, and Med, were detected in N 1
rom a normal lymph node, indicating that normal hosts
lso can be infected with multiple strains. PT 1 also
arbors three strains, China 1, B95-8, and China 2. This
inding may be due to strains acquired via transfusions
ither preceding or following transplantation. Two NPCs,
9 and 36, of 62 had two strains of EBV. Clonal EBV was
etected in NPC 36, suggesting that either the progenitor
ell was simultaneously infected by two strains that
ormed episomes containing identical number of termi-
al repeat elements or one strain represents a strain
ound in infiltrating lymphocytes. The clonality of NPC 29
s unknown, so it could be a rare biclonal NPC, or the
resence of two strains could also result from one strain
n tumor tissue and the other from infiltrating lympho-
ytes (Sung et al., 1998).
Previous analyses of the relative prevalence and stud-
es of transmission have been dependent on identifica-
ion of type 1 or type 2 EBNA2 and EBNA3 sequences
Gratama et al., 1990; Lung et al., 1991; Alfieri et al., 1996).
revious studies have revealed that the sequence vari-
tions of LMP1 do not cosegregate with EBV type, al-
hough China 1 LMP1 has been more frequently detected
n type 1 EBV, and China 2 and Alaskan LMP1 have been
ore frequently detected in type 2 EBV (Abdel-Hamid et
l., 1992; Sung et al., 1998; Cheung et al., 1998). The lack
f correlation between EBNA2 and LMP1 variants may
lso reflect recombination that has occurred. The iden-
ification of sequence changes in LMP1 that clearly dis-
A
ution of the EBV Strains
ina 3 Med Alaskan NC B95-8
1% 1% 5%
90% 10%
11% 9% 35%
22% 1% 6% 21%
100%
e C-terminal sequence) combining the data in this study (78 samples)
ed one of the seven strains based on sequence changes in the C-BLE 3
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91AMINO ACID CHANGES IN LMP1 DISTINGUISH EBVate study of transmission and facilitate the detection of
ossible strain prevalence in distinct infections.
MATERIALS AND METHODS
umor samples and cell lines
The 92 EBV-positive specimens included the following:
PCs 1–15 were from northeastern China (nonendemic
egion); NPCs 16–34, 61, 62, and NPC Cao were from
TA
Disease Distri
China 1 China 2
ormal
33 European 27%
28 Asian 93%
3 US 33%
odgkin’s Disease
34 European 56%
1 Asian 100%
ononucleosis
22 US 50% 9%
10 European 30%
3 Asian 33% 33%
-cell lymphoma
7 European 43%
14 Asian 93%
PD
6 European 67%
16 Asian 63% 25%
onsillar hyperplasia
15 European 67%
TLD
32 US 41%
arcinoma
30 Asian 97% 3%
1 Alaskan
PC
187 Asian 85% 8%
9 Med
2 US 100%
1 Alaskan
ILD
3 European 67%
LP
19 US 47% 5%
1 European
astric tumors
11 Asian 91% 9%
ost Transplant/no disease
4 US 25% 25%
2 European
hronic EBV
7 Asian 86% 14%
urkitt’s lymphoma
1 African
1 US
Note. Disease distribution of the seven EBV strains as determined b
thers cited in the discussion (423 samples).outhern China (endemic region); NPCs 35–47 were from galaysia, but of Chinese origin; NPCs 48–52 were Malay-
ian in origin; NPC 1510 was from Taiwan; NPCs 53–56 as
ell as NPCs C15, C17, C18, and C19 were Mediterranean
n origin; NPC 57–59 were American in origin; NPC 60 as
ell as Par 1 were Alaskan in origin; HLP 8 was from
cotland; HLPs 1–7, 9–11, PTL 1–2, PT 1–2, N 1, Mono 1–2,
L 1, and B lymphoid cell line B95-8 (mononucleosis) were
merican in origin; and B lymphoid cell lines AG876, Raji,
91, and P3HR1 (Burkitt’s lymphomas) were African in ori-
B
of the Strains
ina 3 Med Alaskan NC B95-8
12% 18% 42%
7%
33% 33%
12% 3% 29%
23% 4% 14%
10% 30% 30%
33%
14% 43%
7%
17% 17%
12%
33%
19% 13% 28%
100%
% 6%
89% 11%
100%
33%
32% 5% 10%
100%
50%
100%
100%
100%
-terminal sequence combining the data in this study (78 samples) andBLE 3
bution
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1
y the Cin. Viral replication in HLP was confirmed by the identifi-
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92 EDWARDS, SEILLIER-MOISEIWITSCH, AND RAAB-TRAUBation of the EBV termini (Gilligan, et al., 1990). Lowercase
etters following the sample number denote the recovery of
ore than one isolate from the same sample.
The LMP1 sequence of the following samples has
een previously described: NPCs 1–15, 18–29, and 31–33
Sung et al., 1998); NPCs 16–17, 34–35, 53–60, C15, C17,
ar 1, PTLs 1–2, W91, and P3HR1 (Miller et al., 1994,
998); NPC Cao (Hu et al., 1991); NPC 1510 (Chen et al.,
992); B95-8 (Baer et al., 1984); AG876 (Sample et al.,
994); Raji (Hatful et al., 1988); and HLPs 1–8 and Mono
(Walling et al., 1999).
umor processing and isolation of genomic DNA
Frozen tumors were processed as described previ-
usly (Raab-Traub et al., 1983). Tumor specimens were
ulverized in a microdismembrator and suspended in 4
guanidine isothiocyanate (GITC). Peripheral blood
ymphocytes were purified over lymphocyte separation
edia (Organon Teknika, Durham, NC), washed, and
esuspended in GITC. After centrifugation through a ce-
ium chloride step gradient, the DNA was dialyzed, di-
ested with proteinase K, and phenol–chloroform ex-
racted. Paraffin-embedded samples were extracted
wice with octane, washed twice with absolute ethanol,
roteinase K digested, and heated to 95°C for 10 min.
NA sequencing
The DNA sequence corresponding to LMP1 was de-
ermined by first amplifying 0.3 mg of tumor DNA with the
olymerase chain reaction (PCR) using Taq polymerase
Promega, Madison, WI), vent polymerase (New England
iolabs, Beverly, MA), or Expand High Fidelity PCR Sys-
em (Boehringer Mannhein, Indianapolis, IN). The amino-
erminal portion of LMP1 from 77 tissue specimens or
ell lines was amplified using primers LMP9233 and
MP9600A, LMP FUE and FUB, or LMP FUE and 168808
Table 4), followed by asymmetric amplification and
ideoxy sequencing using the same primers as previ-
usly described (Miller et al., 1994). The carboxyl-termi-
T
Sequence of the Primers Used in
Primers EBV coordinates
LMP9233 169233–169250
LMP9600A 168597–169611
LMPFUE 168163–168183
LMPFUB 168733–168756
LMP8808 168808–168830
LMP3UT 168016–168035
LMPEco 169607–169627
LMPFUBR 168733–168756
LMPIN 169130–169149
LMPREP5 168575–168594al portion of LMP1 was determined in 45 specimens by tirst amplifying with primers LMP3UT and 168808 (Table
). This product was Qiaquick (Qiagen, Studio City, CA)
urified, and dideoxy sequenced with the same primers.
or those samples where we were able to amplify the
ull-length LMP1 sequence, the DNA was first amplified
ith primers LMP3UT and LMPEco (Table 4). This prod-
ct was Qiaquick purified, restriction digested with EcoRI
nd HindIII, and cloned into pGem3Z (Promega). Plasmid
NA from individual clones was sequenced using the
ideoxynucleotide chain termination method (Seque-
ase; Amersham, Arlington Heights, IL) and primers
MPFUE, LMPIN, 168808, FUBR, LMP3UT, and LMPEco
Table 4). Of the 23 samples cloned, 14 had more than
ne clone sequenced to confirm the sequence data.
reviously published samples NPCs 16, 59, and 60 and
TLs 1 and 2 were further analyzed for the complete
arboxyl-terminal region by amplification with primers
ep5 and LMP3UT followed by asymmetric PCR and
equencing using the same primers (Table 4). Some of
he samples were sequenced at the University of North
arolina–Chapel Hill Automated DNA Sequencing Facil-
ty on a model 377 DNA Sequencer (Applied Biosystems
ivision, Perkin–Elmer Cetus, Norwalk, CT) using the ABI
RISM Dye Terminator Cycle Sequencing Ready Reac-
ion Kit with AmpliTaq DNA Polymerase, FS (Applied
iosystems Division, Perkin–Elmer Cetus.
hylogenetic and CART analyses
To determine the phylogenetic relationships within the
arious EBV sequence samples representing various
isease states and from the various geographical re-
ions, the LMP1 sequence, including codons 1–70 and
92–386, was compiled from the 92 specimens. Se-
uences were aligned and distance matrices were cal-
ulated with the PHYLIP DNADIST program (Felsenstein,
995), using the Jukes-Cantor (1969), Kimura (1983) two-
arameter model with a transition/transversion ratio
ixed at 2 and a site-dependent model with two param-
ters at each position (Felsenstein, 1995). Phylogenetic
R and Sequencing of the Isolates
Sequence
59TCCAAGTGGACAGAGAAG39
59CAGACCCCGCAAATC39
59GTCATAGTAGCTTAGCTGAAC39
59CAACGACACAGTGATGAACACCAC39
59GTGGACTCTATTGGTTGATCTC39
59ATCACGAGGAATTCAATGTGGCTTTTCAGCCTAG39
59ATCACGAGGAATTCCCCGTACTGCCTCCGGCAGAC39
59GTGGTGTTCATCACTGTGTCGTTG39
59TGGGGAAAGAGGAGAAAGTG39
59GGCGCACCTGGAGGTGGTCCABLE 4
the PCrees were constructed from these distance matrices by
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93AMINO ACID CHANGES IN LMP1 DISTINGUISH EBVoth the neighbor-joining (Saitou and Nei, 1987) and
PGMA, average linkage clustering (Nei, 1975), meth-
ds, using the NEIGHBOR and DRAWTREE programs
rom the PHYLIP package (Felsenstein, 1995).
CART methodology (Breiman et al., 1984) was used to
onstruct classification trees to determine amino acid
ositions that are predictive of a particular grouping
sing the sequence from the 92 tissue specimens or cell
ines described above. For the amino-terminal region, 58
equence samples were analyzed over 16 amino acid
ositions, which included only those loci at which an
mino acid change had occurred in more than one iso-
ate. For the carboxyl-terminal region, 53 sequence sam-
les were analyzed over 44 positions, and for full-length
nalysis, 26 sequence samples were analyzed over 48
ositions. Any duplicates of the same strain from the
ame tissue were eliminated. The CART analysis was
erformed with the isolates grouped by disease, geo-
raphical region, and phylogenetic relationships.
alculation and statistical analysis of error rates of
ost and viral polymerases
To calculate the error rate of the host and viral poly-
erases, the samples were divided into latent infection,
hich included isolates from NPC, N, PT, and BL, or
ermissive infection, which included isolates from HLP,
o represent host or viral polymerase. The carboxyl-ter-
inal sequence, which covered 592 nucleotides per
ample, was used. For each strain, the total number of
hanges outside the signature were compared with the
otal number of nucleotides, and in the case of more than
ne sample of the same strain from a given specimen,
he sample with the most changes outside the signature
as used. From this total number of changes outside the
ignature and the total number of nucleotides, a mean
ercent error was calculated for the different poly-
erases. To determine whether the difference in error
ates was significant between the two polymerases, the
ata were analyzed using a binomial test for the differ-
nce in proportions. P values were generated via a
inomial test comparing the proportion of changes out-
ide the signature for latent infection with that for per-
issive infection for each strain.
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